Acute and chronic nicotine exposures modulate the immune system through different pathways.

Area of Science:

• Immunology
• Pharmacology
• Endocrinology

Background:

• Chronic nicotine exposure leads to T cell anergy and impaired proliferation.
• Nicotine's effects on T cells persist post-exposure and involve altered calcium signaling and kinase activity.

Purpose of the Study:

• To investigate the distinct mechanisms of acute versus chronic nicotine's effects on T cell proliferation.
• To determine if acute and chronic nicotine treatments inhibit T cell proliferation identically.

Main Methods:

• LEW rats received acute nicotine (1, 2, or 24h) or chronic nicotine (3-week pump).
• T cell proliferation assays (Con A-induced) were performed on peripheral blood cells (PBC) and spleen cells.
• Mechanisms explored included T cell receptor (TCR) signaling, protein tyrosine kinase (PTK) and phospholipase C (PLC)-gamma1 activity, and corticosterone levels.

Main Results:

• Both acute and chronic nicotine inhibited T cell proliferation, reversible by mecamylamine (MEC), indicating nicotinic receptor involvement.
• Acute nicotine's effect was transient (1-2h) and primarily in PBC, without altering TCR signaling or kinase activity.
• Chronic nicotine induced T cell anergy, decreased calcium response, and constitutive PTK/PLC-gamma1 activity.
• Acute nicotine increased corticosterone, mediated by MEC and abrogated by adrenalectomy, suggesting hypothalamus-pituitary-adrenal (HPA) axis activation.

Conclusions:

• Acute and chronic nicotine exposure exert distinct effects on T lymphocytes.
• Chronic nicotine induces T cell anergy through direct effects on T cells.
• Acute nicotine's immunosuppressive effects are primarily mediated by the HPA axis activation.